Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes)
Clinical Genetic Test
offered by
GTR Test Accession: Help GTR000607982.2
Last updated in GTR: 2023-08-18
Last annual review date for the lab: 2024-07-05 LinkOut
At a Glance
Diagnosis; Mutation Confirmation; Risk Assessment; ...
Breast-ovarian cancer, familial, susceptibility to, 1; Ataxia-telangiectasia syndrome; BAP1-related tumor predisposition syndrome more...
APC (5q22.2); ATM (11q22.3); BAP1 (3p21.1); BARD1 (2q35); BMPR1A (10q23.2) more...
Molecular Genetics - Mutation scanning of select exons: Next-Generation (NGS)/Massively parallel sequencing (MPS)
The GDI Inherited Cancer Sequencing Panels are recommended for patients …
Not provided
Predictive risk information for patient and/or family members
Ordering Information
Offered by: Help
Specimen Source: Help
Who can order: Help
  • Health Care Provider
  • Nurse Practitioner
Test Order Code: Help
Informed consent required: Help
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 47
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 41
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Total methods: 1
Method Category Help
Test method Help
Instrument *
Mutation scanning of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Mutation Confirmation; Risk Assessment; Screening
Clinical utility: Help
Predictive risk information for patient and/or family members
View citations (1)
  • LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN, Yadav S, Hu C, Na J, Goldgar DE, Fulk K, Smith LP, Horton C, Profato J, Pesaran T, Gau CL, Pronold M, Davis BT, Chao EC, Couch FJ, Dolinsky JS. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med. 2020;22(2):407-415. doi:10.1038/s41436-019-0633-8. Epub 2019 Aug 13. PMID: 31406321.

Target population: Help
The GDI Inherited Cancer Sequencing Panels are recommended for patients with a personal or family history of cancer or have a family member that has been positively screened for a variant implicated in cancer in a gene that is covered by this panel.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
The GDI Inherited Cancer Sequencing Common Hereditary Cancer Panel sequences 41 genes and was validated with a sensitivity and specificity of 100% and 100%, respectively.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
College of American Pathologists, CAP

CAP Testing Information Help
CAP/ACMG BRCA1/2 Sequencing; BRCA1/2 sequencing; BRCA
Next-Generation Sequencing-Germline; Next-generation sequencing; NGS
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.